2BB score and signals
Cadrenal Therapeutics, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 39 | Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 20 | Weak |
| Risk | 51 | Moderate |
Company facts
| Founded | 2022 |
| Employees | 5 |
| 52-week range | $1.76 – $14.64 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -1.3158 | — | $0.00 |
| 2026-08-10 | — | -1.4484 | — | $0.00 |
| 2026-05-07 | -1.04 | -1.6524 | $0.00 | $0.00 |
| 2026-03-31 | -1.43 | -1.1883 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish